The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Agenus Inc | COM | 00847G705 | 608,160 | 253,400 | SH | Call | SOLE | 253,400 | 0 | 0 | ||
Agenus Inc | COM | 00847G705 | 2,432,640 | 1,013,600 | SH | Call | SOLE | 1,013,600 | 0 | 0 | ||
Agenus Inc | COM | 00847G705 | 6,945,737 | 2,894,057 | SH | SOLE | 2,894,057 | 0 | 0 | |||
Align Technology Inc | COM | 016255101 | 17,525,790 | 83,100 | SH | SOLE | 83,100 | 0 | 0 | |||
Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 23,765,000 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | ||
Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 13,414,867 | 56,448 | SH | SOLE | 56,448 | 0 | 0 | |||
Arcus Biosciences Inc | COM | 03969F109 | 6,510,291 | 314,811 | SH | SOLE | 314,811 | 0 | 0 | |||
AstraZeneca PLC | SPONSORED ADR | 046353108 | 41,607,029 | 613,673 | SH | SOLE | 613,673 | 0 | 0 | |||
Biomarin Pharmaceutical Inc | COM | 09061G101 | 40,841,604 | 394,643 | SH | SOLE | 394,643 | 0 | 0 | |||
CTI Biopharma Corp | COM | 12648L601 | 27,685,227 | 4,606,527 | SH | SOLE | 4,606,527 | 0 | 0 | |||
CTI Biopharma Corp | COM | 12648L601 | 2,464,100 | 410,000 | SH | Call | SOLE | 410,000 | 0 | 0 | ||
Chinook Therapeutics Inc | COM | 16961L106 | 21,129,226 | 806,459 | SH | SOLE | 806,459 | 0 | 0 | |||
Cytokinetics Inc | COM | 23282W605 | 4,582,000 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | ||
Cytokinetics Inc | COM | 23282W605 | 23,319,173 | 508,930 | SH | SOLE | 508,930 | 0 | 0 | |||
Dexcom Inc | COM | 252131107 | 15,930,377 | 140,678 | SH | SOLE | 140,678 | 0 | 0 | |||
Fulcrum Therapeutics Inc | COM | 359616109 | 4,596,672 | 631,411 | SH | SOLE | 631,411 | 0 | 0 | |||
Geron Corp | COM | 374163103 | 3,532,205 | 1,459,589 | SH | SOLE | 1,459,589 | 0 | 0 | |||
Geron Corp | COM | 374163103 | 5,733,222 | 2,369,100 | SH | Call | SOLE | 2,369,100 | 0 | 0 | ||
Horizon Therapeutics PLC | SHS | G46188101 | 47,019,087 | 413,173 | SH | SOLE | 413,173 | 0 | 0 | |||
IDEAYA Biosciences Inc | COM | 45166A102 | 8,622,210 | 474,530 | SH | SOLE | 474,530 | 0 | 0 | |||
Immatics NV | SHS | N44445109 | 17,426,759 | 2,000,776 | SH | SOLE | 2,000,776 | 0 | 0 | |||
ImmunoGen Inc | COM | 45253H101 | 8,363,324 | 1,686,154 | SH | SOLE | 1,686,154 | 0 | 0 | |||
Inhibrx Inc | COM | 45720L107 | 27,354,909 | 1,110,183 | SH | SOLE | 1,110,183 | 0 | 0 | |||
Iveric Bio Inc | COM | 46583P102 | 13,668,101 | 638,398 | SH | SOLE | 638,398 | 0 | 0 | |||
Karuna Therapeutics Inc | COM | 48576A100 | 134,210 | 683 | SH | SOLE | 683 | 0 | 0 | |||
Kura Oncology Inc | COM | 50127T109 | 7,366,092 | 593,561 | SH | SOLE | 593,561 | 0 | 0 | |||
Merck & Co Inc | COM | 58933Y105 | 66,942,348 | 603,356 | SH | SOLE | 603,356 | 0 | 0 | |||
Prometheus Biosciences Inc | COM | 74349U108 | 19,419,950 | 176,545 | SH | SOLE | 176,545 | 0 | 0 | |||
Reata Pharmaceuticals Inc | CL A | 75615P103 | 37,687,182 | 992,029 | SH | SOLE | 992,029 | 0 | 0 | |||
Sanofi SA | SPONSORED ADR | 80105N105 | 95,187,954 | 1,965,475 | SH | SOLE | 1,965,475 | 0 | 0 | |||
Sarepta Therapeutics Inc | COM | 803607100 | 32,130,009 | 247,955 | SH | SOLE | 247,955 | 0 | 0 | |||
Syndax Pharmaceuticals Inc | COM | 87164F105 | 17,893,233 | 703,074 | SH | SOLE | 703,074 | 0 | 0 | |||
Travere Therapeutics Inc | COM | 89422G107 | 12,160,976 | 578,268 | SH | SOLE | 578,268 | 0 | 0 | |||
United Therapeutics Corp | COM | 91307C102 | 24,807,575 | 89,207 | SH | SOLE | 89,207 | 0 | 0 | |||
Vertex Pharmaceuticals Inc | COM | 92532F100 | 45,335,283 | 156,989 | SH | SOLE | 156,989 | 0 | 0 | |||
Zentalis Pharmaceuticals Inc | COM | 98943L107 | 20,221,466 | 1,004,045 | SH | SOLE | 1,004,045 | 0 | 0 | |||
Aerovate Therapeutics Inc | COM | 008064107 | 110,129,500 | 3,758,686 | SH | SOLE | 3,758,686 | 0 | 0 | |||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 107,572,104 | 880,800 | SH | SOLE | 880,800 | 0 | 0 | |||
Bolt Biotherapeutics Inc | COM | 097702104 | 3,580,768 | 2,754,437 | SH | SOLE | 2,754,437 | 0 | 0 | |||
Cincor Pharma Inc | COM | 17240Y109 | 74,648,833 | 6,073,949 | SH | SOLE | 6,073,949 | 0 | 0 | |||
Fusion Pharmaceuticals Inc | COM | 36118A100 | 368,862 | 117,099 | SH | SOLE | 117,099 | 0 | 0 | |||
Galera Therapeutics Inc | COM | 36338D108 | 4,594,731 | 3,083,712 | SH | SOLE | 3,083,712 | 0 | 0 | |||
Inozyme Pharma Inc | COM | 45790W108 | 3,838,073 | 3,655,308 | SH | SOLE | 3,655,308 | 0 | 0 | |||
Karuna Therapeutics Inc | COM | 48576A100 | 407,234,657 | 2,072,441 | SH | SOLE | 2,072,441 | 0 | 0 | |||
Natera Inc | COM | 632307104 | 124,549,495 | 3,100,560 | SH | SOLE | 3,100,560 | 0 | 0 | |||
Nextcure Inc | COM | 65343E108 | 3,767,317 | 2,671,856 | SH | SOLE | 2,671,856 | 0 | 0 | |||
Nucana PLC | SPONSORED ADR | 67022C106 | 3,695,999 | 5,599,999 | SH | SOLE | 5,599,999 | 0 | 0 | |||
Nucana PLC | COMMON SHARES | GB00BYWYV | 1,584,000 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | |||
ObsEva SA | COM | H5861P103 | 688,695 | 4,749,623 | SH | SOLE | 4,749,623 | 0 | 0 | |||
PDS Biotechnology Corp | COM | 70465T107 | 1,882,782 | 142,635 | SH | SOLE | 142,635 | 0 | 0 | |||
Synlogic Inc | COM | 87166L100 | 436,979 | 574,972 | SH | SOLE | 574,972 | 0 | 0 | |||
Vera Therapeutics Inc | CL A | 92337R101 | 61,560,903 | 3,181,442 | SH | SOLE | 3,181,442 | 0 | 0 | |||
Y-mAbs Therapeutics Inc | COM | 984241109 | 10,708,077 | 2,194,278 | SH | SOLE | 2,194,278 | 0 | 0 |